AGŐćČ˹ٷ˝

STOCK TITAN

Springworks Therapeutics, Inc. SEC Filings

SWTX NASDAQ

Welcome to our dedicated page for Springworks Therapeutics SEC filings (Ticker: SWTX), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.

Clinical trial footnotes, R&D cost drivers, milestone payments, and FDA status hide deep in SpringWorks Therapeuticsâ€� multi-section 10-K. For analysts chasing desmoid-tumor data or confirming cash runway before the next pivotal read-out, scrolling hundreds of biotech pages wastes hours. The challenge intensifies when insider activity posts on Form 4 minutes after market close. Investors need answers fast, not another PDF.

Stock Titan surfaces what matters the instant an SWTX document hits EDGAR. Our AI-powered summaries translate scientific jargon and accounting detail into plain English, delivering real-time filing updates as they’re published to EDGAR. Whether you’re reviewing a SpringWorks Therapeutics quarterly earnings report 10-Q filing, scanning an unexpected 8-K material event, or comparing figures in the latest SpringWorks Therapeutics proxy statement executive compensation disclosure, our platform highlights pipeline updates, royalty obligations, and cash burn without line-by-line reading.

Every filing type is covered:

  • SpringWorks Therapeutics insider trading Form 4 transactions with alert history
  • SpringWorks Therapeutics quarterly earnings report 10-Q filing trend charts
  • SpringWorks Therapeutics executive stock transactions Form 4 in real time
  • SpringWorks Therapeutics annual report 10-K simplified for quick reference
  • SpringWorks Therapeutics 8-K material events explained
  • Understanding SpringWorks Therapeutics SEC documents with AI

Stop guessing when executives sell shares or when milestone payments hit the balance sheet. With expert annotations, keyword search across all SpringWorks Therapeutics filings, and side-by-side PDF comparison, you get SpringWorks Therapeutics earnings report filing analysis in seconds—clarity and speed every time the company presses “submit.�

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
other

FAQ

What is the current stock price of Springworks Therapeutics (SWTX)?

The current stock price of Springworks Therapeutics (SWTX) is $46.99 as of July 2, 2025.

What is the market cap of Springworks Therapeutics (SWTX)?

The market cap of Springworks Therapeutics (SWTX) is approximately 3.5B.
Springworks Therapeutics, Inc.

NASDAQ:SWTX

SWTX Rankings

SWTX Stock Data

3.54B
73.28M
1.28%
87.4%
8.47%
Biotechnology
Biological Products, (no Disgnostic Substances)
United States
STAMFORD